Oxidized Ca2+/Calmodulin-Dependent Protein Kinase II Triggers Atrial Fibrillation

Anil Purohit, Adam G. Rokita, Xiaoqun Guan, Biyi Chen, Olha M. Koval, Niels Voigt, Stefan Neef, Thomas Sowa, Zhan Gao, Elizabeth Luczak, Hrafnhildur Stefansdottir, Andrew C. Behunin, Na Li, Ramzi N. El-Accaoui, Baoli Yang, Paari Dominic Swaminathan, Robert M. Weiss, Xander H T Wehrens, Long Sheng Song, Dobromir DobrevLars S. Maier, Mark Anderson

Research output: Contribution to journalArticle

Abstract

BACKGROUND-: Atrial fibrillation (AF) is a growing public health problem without adequate therapies. Angiotensin II and reactive oxygen species are validated risk factors for AF in patients, but the molecular pathways connecting reactive oxygen species and AF are unknown. The Ca/calmodulin-dependent protein kinase II (CaMKII) has recently emerged as a reactive oxygen species-activated proarrhythmic signal, so we hypothesized that oxidized CaMKIIδ could contribute to AF. METHODS AND RESULTS-: We found that oxidized CaMKII was increased in atria from AF patients compared with patients in sinus rhythm and from mice infused with angiotensin II compared with mice infused with saline. Angiotensin II-treated mice had increased susceptibility to AF compared with saline-treated wild-type mice, establishing angiotensin II as a risk factor for AF in mice. Knock-in mice lacking critical oxidation sites in CaMKIIδ (MM-VV) and mice with myocardium-restricted transgenic overexpression of methionine sulfoxide reductase A, an enzyme that reduces oxidized CaMKII, were resistant to AF induction after angiotensin II infusion. CONCLUSIONS-: Our studies suggest that CaMKII is a molecular signal that couples increased reactive oxygen species with AF and that therapeutic strategies to decrease oxidized CaMKII may prevent or reduce AF.

Original languageEnglish (US)
Pages (from-to)1748-1757
Number of pages10
JournalCirculation
Volume128
Issue number16
DOIs
StatePublished - Oct 15 2013
Externally publishedYes

Fingerprint

Calcium-Calmodulin-Dependent Protein Kinase Type 2
Atrial Fibrillation
Angiotensin II
Reactive Oxygen Species
Methionine Sulfoxide Reductases
Myocardium
Public Health

Keywords

  • angiotensin II
  • arrhythmias, cardiac
  • atrial fibrillation
  • calcium-calmodulin-dependent protein kinase type II
  • reactive oxygen species

ASJC Scopus subject areas

  • Physiology (medical)
  • Cardiology and Cardiovascular Medicine

Cite this

Oxidized Ca2+/Calmodulin-Dependent Protein Kinase II Triggers Atrial Fibrillation. / Purohit, Anil; Rokita, Adam G.; Guan, Xiaoqun; Chen, Biyi; Koval, Olha M.; Voigt, Niels; Neef, Stefan; Sowa, Thomas; Gao, Zhan; Luczak, Elizabeth; Stefansdottir, Hrafnhildur; Behunin, Andrew C.; Li, Na; El-Accaoui, Ramzi N.; Yang, Baoli; Swaminathan, Paari Dominic; Weiss, Robert M.; Wehrens, Xander H T; Song, Long Sheng; Dobrev, Dobromir; Maier, Lars S.; Anderson, Mark.

In: Circulation, Vol. 128, No. 16, 15.10.2013, p. 1748-1757.

Research output: Contribution to journalArticle

Purohit, A, Rokita, AG, Guan, X, Chen, B, Koval, OM, Voigt, N, Neef, S, Sowa, T, Gao, Z, Luczak, E, Stefansdottir, H, Behunin, AC, Li, N, El-Accaoui, RN, Yang, B, Swaminathan, PD, Weiss, RM, Wehrens, XHT, Song, LS, Dobrev, D, Maier, LS & Anderson, M 2013, 'Oxidized Ca2+/Calmodulin-Dependent Protein Kinase II Triggers Atrial Fibrillation', Circulation, vol. 128, no. 16, pp. 1748-1757. https://doi.org/10.1161/CIRCULATIONAHA.113.003313
Purohit A, Rokita AG, Guan X, Chen B, Koval OM, Voigt N et al. Oxidized Ca2+/Calmodulin-Dependent Protein Kinase II Triggers Atrial Fibrillation. Circulation. 2013 Oct 15;128(16):1748-1757. https://doi.org/10.1161/CIRCULATIONAHA.113.003313
Purohit, Anil ; Rokita, Adam G. ; Guan, Xiaoqun ; Chen, Biyi ; Koval, Olha M. ; Voigt, Niels ; Neef, Stefan ; Sowa, Thomas ; Gao, Zhan ; Luczak, Elizabeth ; Stefansdottir, Hrafnhildur ; Behunin, Andrew C. ; Li, Na ; El-Accaoui, Ramzi N. ; Yang, Baoli ; Swaminathan, Paari Dominic ; Weiss, Robert M. ; Wehrens, Xander H T ; Song, Long Sheng ; Dobrev, Dobromir ; Maier, Lars S. ; Anderson, Mark. / Oxidized Ca2+/Calmodulin-Dependent Protein Kinase II Triggers Atrial Fibrillation. In: Circulation. 2013 ; Vol. 128, No. 16. pp. 1748-1757.
@article{65b3c0dce52443dca8fda30b210dfaf5,
title = "Oxidized Ca2+/Calmodulin-Dependent Protein Kinase II Triggers Atrial Fibrillation",
abstract = "BACKGROUND-: Atrial fibrillation (AF) is a growing public health problem without adequate therapies. Angiotensin II and reactive oxygen species are validated risk factors for AF in patients, but the molecular pathways connecting reactive oxygen species and AF are unknown. The Ca/calmodulin-dependent protein kinase II (CaMKII) has recently emerged as a reactive oxygen species-activated proarrhythmic signal, so we hypothesized that oxidized CaMKIIδ could contribute to AF. METHODS AND RESULTS-: We found that oxidized CaMKII was increased in atria from AF patients compared with patients in sinus rhythm and from mice infused with angiotensin II compared with mice infused with saline. Angiotensin II-treated mice had increased susceptibility to AF compared with saline-treated wild-type mice, establishing angiotensin II as a risk factor for AF in mice. Knock-in mice lacking critical oxidation sites in CaMKIIδ (MM-VV) and mice with myocardium-restricted transgenic overexpression of methionine sulfoxide reductase A, an enzyme that reduces oxidized CaMKII, were resistant to AF induction after angiotensin II infusion. CONCLUSIONS-: Our studies suggest that CaMKII is a molecular signal that couples increased reactive oxygen species with AF and that therapeutic strategies to decrease oxidized CaMKII may prevent or reduce AF.",
keywords = "angiotensin II, arrhythmias, cardiac, atrial fibrillation, calcium-calmodulin-dependent protein kinase type II, reactive oxygen species",
author = "Anil Purohit and Rokita, {Adam G.} and Xiaoqun Guan and Biyi Chen and Koval, {Olha M.} and Niels Voigt and Stefan Neef and Thomas Sowa and Zhan Gao and Elizabeth Luczak and Hrafnhildur Stefansdottir and Behunin, {Andrew C.} and Na Li and El-Accaoui, {Ramzi N.} and Baoli Yang and Swaminathan, {Paari Dominic} and Weiss, {Robert M.} and Wehrens, {Xander H T} and Song, {Long Sheng} and Dobromir Dobrev and Maier, {Lars S.} and Mark Anderson",
year = "2013",
month = "10",
day = "15",
doi = "10.1161/CIRCULATIONAHA.113.003313",
language = "English (US)",
volume = "128",
pages = "1748--1757",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "16",

}

TY - JOUR

T1 - Oxidized Ca2+/Calmodulin-Dependent Protein Kinase II Triggers Atrial Fibrillation

AU - Purohit, Anil

AU - Rokita, Adam G.

AU - Guan, Xiaoqun

AU - Chen, Biyi

AU - Koval, Olha M.

AU - Voigt, Niels

AU - Neef, Stefan

AU - Sowa, Thomas

AU - Gao, Zhan

AU - Luczak, Elizabeth

AU - Stefansdottir, Hrafnhildur

AU - Behunin, Andrew C.

AU - Li, Na

AU - El-Accaoui, Ramzi N.

AU - Yang, Baoli

AU - Swaminathan, Paari Dominic

AU - Weiss, Robert M.

AU - Wehrens, Xander H T

AU - Song, Long Sheng

AU - Dobrev, Dobromir

AU - Maier, Lars S.

AU - Anderson, Mark

PY - 2013/10/15

Y1 - 2013/10/15

N2 - BACKGROUND-: Atrial fibrillation (AF) is a growing public health problem without adequate therapies. Angiotensin II and reactive oxygen species are validated risk factors for AF in patients, but the molecular pathways connecting reactive oxygen species and AF are unknown. The Ca/calmodulin-dependent protein kinase II (CaMKII) has recently emerged as a reactive oxygen species-activated proarrhythmic signal, so we hypothesized that oxidized CaMKIIδ could contribute to AF. METHODS AND RESULTS-: We found that oxidized CaMKII was increased in atria from AF patients compared with patients in sinus rhythm and from mice infused with angiotensin II compared with mice infused with saline. Angiotensin II-treated mice had increased susceptibility to AF compared with saline-treated wild-type mice, establishing angiotensin II as a risk factor for AF in mice. Knock-in mice lacking critical oxidation sites in CaMKIIδ (MM-VV) and mice with myocardium-restricted transgenic overexpression of methionine sulfoxide reductase A, an enzyme that reduces oxidized CaMKII, were resistant to AF induction after angiotensin II infusion. CONCLUSIONS-: Our studies suggest that CaMKII is a molecular signal that couples increased reactive oxygen species with AF and that therapeutic strategies to decrease oxidized CaMKII may prevent or reduce AF.

AB - BACKGROUND-: Atrial fibrillation (AF) is a growing public health problem without adequate therapies. Angiotensin II and reactive oxygen species are validated risk factors for AF in patients, but the molecular pathways connecting reactive oxygen species and AF are unknown. The Ca/calmodulin-dependent protein kinase II (CaMKII) has recently emerged as a reactive oxygen species-activated proarrhythmic signal, so we hypothesized that oxidized CaMKIIδ could contribute to AF. METHODS AND RESULTS-: We found that oxidized CaMKII was increased in atria from AF patients compared with patients in sinus rhythm and from mice infused with angiotensin II compared with mice infused with saline. Angiotensin II-treated mice had increased susceptibility to AF compared with saline-treated wild-type mice, establishing angiotensin II as a risk factor for AF in mice. Knock-in mice lacking critical oxidation sites in CaMKIIδ (MM-VV) and mice with myocardium-restricted transgenic overexpression of methionine sulfoxide reductase A, an enzyme that reduces oxidized CaMKII, were resistant to AF induction after angiotensin II infusion. CONCLUSIONS-: Our studies suggest that CaMKII is a molecular signal that couples increased reactive oxygen species with AF and that therapeutic strategies to decrease oxidized CaMKII may prevent or reduce AF.

KW - angiotensin II

KW - arrhythmias, cardiac

KW - atrial fibrillation

KW - calcium-calmodulin-dependent protein kinase type II

KW - reactive oxygen species

UR - http://www.scopus.com/inward/record.url?scp=84885795044&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885795044&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.113.003313

DO - 10.1161/CIRCULATIONAHA.113.003313

M3 - Article

C2 - 24030498

AN - SCOPUS:84885795044

VL - 128

SP - 1748

EP - 1757

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 16

ER -